|
|
english
|
español
|
français
|
Sign Up for an Account
|
Sign In
Country Profiles...
Home
The BCH
The Protocol
Finding Information
Registering Information
Resources
Help
Finding Information
National Contacts
Laws and Regulations
Country's Decisions and other Communications
Submissions
Risk Assessments
Roster of Experts
LMOs, Genes or Organisms
National Reports
Capacity-Building
Organizations
The BCH Virtual Library
Survey on indicators (2014)
Compiled Information
National Contacts
LMO Registry
Organism Registry
Gene Registry
Go to record ID
Home
|
Finding Information
|
Record details
Modified Organism
CGN-89111-8 - High oleic acid canola
LMO Information
Decisions on the LMO
Risk Assessments
Record information and status
Record ID
14780
Status
Published
Date of creation
2006-06-05 14:39 UTC (kirsty.mclean.consultant@cbd.int)
Date of last update
2012-11-13 14:40 UTC (dina.abdelhakim@cbd.int)
Date of publication
2012-11-13 14:40 UTC (dina.abdelhakim@cbd.int)
Tweeter
Living Modified Organism identity
The image below identifies the LMO through its unique identifier, trade name and a link to this page of the BCH. Click on it to download a larger image on your computer. For help on how to use it go to the
LMO quick-links
page.
LMO name
High oleic acid canola
Transformation event
23-18-17 (Event 18)
Unique identifier
CGN-89111-8
Developer(s)
Record #14932
Monsanto (Calgene)
Url:
Monsanto Homepage
Description
The canola line 23-18-17 was genetically engineered to express modified seed fatty acid content, specifically high levels of lauric acid and myristic acid. The increased levels of lauric acid in oil from the modified canola lines allow for its use as a replacement for other lauric acid oils, such as coconut and palm kernel oil, in products such as confectionery coatings and fillings, margarines, spreads, shortenings and commercial frying oils.
The modified fatty acid content of 23-18-17 is a result of the insertion of a thioesterase (TE) encoding gene from the California bay tree, Umbellularia californica, which is an alternative source of the spice "bay leaf" that is harvested commercially from Lauris nobilis. The introduced thioesterase enzyme is active in the fatty acid biosynthetic pathway of the developing seed and causes the accumulation of triacylglycerides containing esterified lauric acid and, to a lesser extent, myristic acid.
Recipient Organism or Parental Organisms
The term Recipient organism refers to an organism (either already modified or non-modified) that was subjected to genetic modification, whereas Parental organisms refers to those that were involved in cross breeding or cell fusion.
Record #12083
Brassica napus - Turnip, Rapeseed, Canola Plant, Oilseed Rape, Rape, BRANA
Related LMOs
Record #14782
CGN-89465-2 - High oleic acid canola
Production of medical or pharmaceutical compounds (human or animal) - Omega-3 fatty acids (e.g. DHA) Resistance to antibiotics - Kanamycin
Characteristics of the transformation process
Vector
pCGN3828-212/86-18
Techniques used for the modification
Agrobacterium-mediated DNA transfer
Genetic elements construct
Napin gene promoter
#104354
0.00 Kb
Thioesterase
#15005
0.00 Kb
Napin gene terminator
#104355
0.00 Kb
CaMV 35S promoter
#100287
0.00 Kb
Neomycin Phosphotransferase II
#15001
0.00 Kb
Tumour Morphology Large gene terminator
#104340
0.00 Kb
Further details
Notes regarding the genetic elements introduced or modified in this LMO
The original transformation event 23 was estimated to have 15 copies of the genes, at five independent genetic loci, as shown by Southern and segregation analyses. Lines 23-198 and 23-18-17 are several generations removed from the original transformant. Mendelian inheritance, and Southern and PCR analyses of third-generation material show the stability of the introduced genes as the bands did not change position. Some of the copies are segregating out, as expected, so that these lines may not be homogeneous for the number of copies present.
LMO characteristics
Modified traits
Production of medical or pharmaceutical compounds (human or animal)
Omega-3 fatty acids (e.g. DHA)
Resistance to antibiotics
Kanamycin
Additional Information
Other relevant website address or attached documents
OECD UID Database
CERA GM Database
High oleic acid canola - APHIS
Records referencing this document
(
3
)
ID
Description
3
record(s) found
Country's Decision or any other Communication
1 record
Modified Organism
1 record
Risk Assessment
1 record
Contact us
|
Site Map
|
Linkages Policy
|
Privacy Policy
|
Disclaimer
|
© SCBD 2001-2016
Rate this page
- 65 people have rated this page